Michael Scolaro

Michael Scolaro

Sep 20, 2017

Group 6 Copy 698
-1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

How does involvement in kink, fetish or BDSM impact a person's health?

Kink-involved people engage in atypical erotic activities such as bondage, rough sex, and fetish activities...

How does our blood absorb light?

Light has been shown to have anti-depressant effects (just think about your mood when it's sunny!). But...

Early-Stage Drug Discovery for Chagas' Disease

An estimated 6 – 7 million people in Latin America and 300,000 U.S. citizens are infected with the protozoan...

Backer Badge Funded